Prognostic value of test(s) for O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide - McAleenan, A; Kelly, C; Spiga, F (Cochrane Database Syst Rev, 2021)